Literature DB >> 14982718

Validation of the Algase Wandering Scale (Version 2) in a cross cultural sample.

D L Algase1, E R A Beattie, J-A Song, D Milke, C Duffield, B Cowan.   

Abstract

This study examined the psychometric properties of an expanded version of the Algase Wandering Scale (Version 2) (AWS-V2) in a cross-cultural sample. A cross-sectional survey design was used. Study subjects were 172 English-speaking persons with dementia (PWD) from long-term care facilities in the USA, Canada, and Australia. Two or more facility staff rated each subject on the AWS-V2. Demographic and cognitive data (MMSE) were also obtained. Staff provided information on their own knowledge of the subject and of dementia. Separate factor analyses on data from two samples of raters each explained greater than 66% of the variance in AWS-V2 scores and validated four (persistent walking, navigational deficit, eloping behavior, and shadowing) of five factors in the original scale. Items added to create the AWS-V2 strengthened the shadowing subscale, failed to improve the routinized walking subscale, and added a factor, attention shifting as compared to the original AWS. Evidence for validity was found in significant correlations and ANOVAs between the AWS-V2 and most subscales with a single item indicator of wandering and with the MMSE. Evidence of reliability was shown by internal consistency of the AWS-V2 (0.87, 0.88) and its subscales (range 0.88 to 0.66), with Kappa for individual items (17 of 27 greater than 0.4), and ANOVAs comparing ratings across rater groups (nurses, nurse aids, and other staff). Analyses support validity and reliability of the AWS-V2 overall and for persistent walking, spatial disorientation, and eloping behavior subscales. The AWS-V2 and its subscales are an appropriate way to measure wandering as conceptualized within the Need-driven Dementia-compromised Behavior Model in studies of English-speaking subjects. Suggestions for further strengthening the scale and for extending its use to clinical applications are described.

Entities:  

Mesh:

Year:  2004        PMID: 14982718     DOI: 10.1080/13607860410001649644

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  4 in total

1.  Evaluating the effects of a physical activity on agitation and wandering (PAAW) experienced by individuals living with a dementia in care homes.

Authors:  Victoria Traynor; Nadine Veerhuis; Keryn Johnson; Jessica Hazelton; Shiva Gopalan
Journal:  J Res Nurs       Date:  2018-03-14

Review 2.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

3.  The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases.

Authors:  Noam Shoval; Gail K Auslander; Tim Freytag; Ruth Landau; Frank Oswald; Ulrich Seidl; Hans-Werner Wahl; Shirli Werner; Jeremia Heinik
Journal:  BMC Geriatr       Date:  2008-03-26       Impact factor: 3.921

Review 4.  What do we know about strategies to manage dementia-related wandering? A scoping review.

Authors:  Noelannah A Neubauer; Peyman Azad-Khaneghah; Antonio Miguel-Cruz; Lili Liu
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.